Background
==========

Biological processes are underlain by interactions between various genes and their products through defined pathways in the molecular network, in which molecules cross communicate in hitherto unknown ways under both healthy and disease conditions. Learning gene expression patterns on a genomic scale would substantially help deconvolute these complex processes. Exhaustive identification of human genes during the Human Genome Project has made such studies possible. By global gene expression profiling in cells and tissues under either physiological or *in vitro*conditions, our understanding of the correlation between gene functions and their phenotypic effects could be significantly enhanced.

The advent of the microarray-based high-throughput RNA detection system \[[@B1],[@B2]\] has made it possible to profile gene expression patterns for the entire transcriptome. However, to detect gene transcripts very specifically, one needs to discriminate them from closely related sequences including: (1) the corresponding gene sequences. Although contamination of gene sequences may not be a concern for applications using purified mRNA, gene sequences must be taken into consideration for applications directly using cell lysate without RNA extraction. This becomes especially important when the studied transcripts are present at low abundance; (2) pseudogenes and their possible transcripts. The number of pseudogenes in the human genome was estimated to be 20,000 to 33,000, which are widely expressed \[[@B3],[@B4]\]. These sequences usually share a high degree of sequence identity with the closely related genes; (3) unprocessed RNA containing the same exons as those of the corresponding mRNA. So far, no system has addressed the above issue very effectively.

Among the microarray-based platforms, GeneChip is a commonly used system and has been improved significantly since it was invented, and has contributed to understanding the complex gene expression network in a great deal. However, since this technology is limited by its high degree of nonspecificity and insensitivity, its application has been limited in molecular network integration. Results from a recent analysis \[[@B5]\] indicated that on the Affymetrix GeneChip U95A/Av2 array, 20,696 (10.5%) probes were nonspecific, which could cross-hybridize to multiple genes, and 18,363 (9.3%) probes missed the target transcript sequences. The numbers of nonspecific and mis-targeted probes on the U133A array were comparable, which were 29,405 (12.1%) and 19,717 (8.0%), respectively \[[@B5]\]. These \~20% of problematic probes certainly and substantially compromise the data accuracy, decrease the value of microarray data, and are not acceptable for the studies of molecular network integration. It was also found that some probe sets representing the same genes on Affymetrix microarrays could show significant discrepancy because of the non-specific hybridization \[[@B6],[@B7]\]

In most applications, gene expression profiling with microarrays including GeneChip requires amplification of sample RNA, regardless of how much material is available. Normally, 1 to 3 μg of RNA is required for each assay \[[@B8]\]. However, high-throughput gene expression profiling with superior sensitivity is becoming more and more demanded, and has its wide applications. For example, in breast cancer research, analysis of specimens from microdissection may provide important information about genes involved in different cancer development stages and for understanding the molecular mechanisms underlying cancer development \[[@B9]\]. Specimens from fine needle biopsy are also important in diagnostic procedures and in evaluating therapeutic effects. The ability to analyze a large number of genes in single cells may help understand the origin and clonality of cancer development and learn the molecular details involved in different stages of the cell cycle.

Current methodologies for gene expression profiling in small RNA samples, especially those from single cells, are very limited. Many of these protocols \[[@B2],[@B10],[@B11]\] require multiple enzymatic reactions that may seriously reduce the sensitivity and compromise the specificity. RNA preparation in most of applications also involves a number of steps, which is rather lengthy, tedious, and requires highly skilled personnel.

To solve the above problems, we have developed a highly specific and sensitive gene expression profiling system. With this system, primers are specially designed to amplify mRNA sequences very specifically. Probes used for microarray detection are designed only to hybridize to sequences amplified from mRNA. In conjunction with the high-throughput multiplex amplification protocol developed in our laboratory lately \[[@B12]\], a large number of mRNA species directly released from very few cells or even single cells can be amplified to a detectable amount without RNA isolation. Amplified products can then be detected by the single-base extension\[[@B13]\] assay on an oligonucleotide microarray \[[@B14]\].

Results
=======

Experimental system used in the study
-------------------------------------

To establish a cancer gene expression array, a panel of cancer-related genes were selected based on their known functions and/or cancer-associated expression patterns from published literature \[[@B15]-[@B28]\]. All amplicon sequences were subjected to computational screening to ensure their uniqueness. Primers and probes were selected according to a series of criteria as specified in Materials and Methods. Most primer pairs amplify sequences in two neighboring exons separated by large introns. The intron lengths ranged from 79 bp to 90 kb with an average of 2.0 kb and 97% of the introns are longer than 200 bp. Initially 1,445 genes were used as the input for the primer and probe design program. Primers and probes were selected for 1,120 (77.5%) of these genes. The remaining 22.5% had either no introns or no suitable sequences for primers and/or probes. Fifteen of these remaining genes with important functions in cancer development were included in the panel. Primers and probes were designed based on the unique sequences in these genes, and were not required to have introns internally located within the amplified sequences. Therefore, a total of 1,135 genes were included in our multiplex assay. (Details about these genes, and their corresponding primers and probes used for the study are listed in Additional files [1](#S1){ref-type="supplementary-material"} and [2](#S2){ref-type="supplementary-material"}.)

Microarray-based single-base extension (SBE) assay has been used to genotype single nucleotide polymorphisms (SNPs) \[[@B12],[@B29],[@B30]\] in our laboratory. In the present study, SBE was adapted for gene expression profiling. To simplify the analysis, all probes were designed to terminate immediately before a \'G\' base in the templates. In this way, the probes were extended by a single base, dideoxynucleoside triphosphate (ddCTP) that was fluorescently labeled. By using one color, the bias associated with different dyes was also eliminated. The detection procedure is schematically illustrated in Fig. [1](#F1){ref-type="fig"}. Resulting data have been deposited to the NCBI\'s Gene Expression Omnibus (GEO) \[[@B31]\] and are accessible through GEO Series accession number GSE5920.

![**Schematic illustration of the high-throughput gene expression profiling procedure**. Fluorescent labeling is indicated by an asterisk.](1471-2164-9-9-1){#F1}

Reproducibility of the high-throughput gene expression profiling system
-----------------------------------------------------------------------

To test the reproducibility of our system, gene expression was profiled for three duplicated 100-cell samples from an ovarian cancer cell line, NCI/ADR-RES \[[@B32]\] and two 100-cell samples from a breast cancer cell line, MCF-7. Resulting microarray data are supplied in Additional file [3](#S3){ref-type="supplementary-material"}. Table [1](#T1){ref-type="table"} summarizes the numbers of gene transcripts detected from different samples. As shown, 660 (58.2%), 663 (58.4%), and 662 (58.3%) gene transcripts were detected from the three 100-cell samples of NCI/ADR-RES, respectively. Of these transcripts, 650 (\>98%) were detected from all three duplicates. Signal intensities for the 1,135 genes were strongly correlated between the duplicates (Pearson\'s r = 0.977, 0.974, and 0.949, respectively). Fig. [2A](#F2){ref-type="fig"} shows a scatter plot of two duplicates. Of the 650 transcripts detected in all three NCI/ADR-RES 100-cell samples, only 6 (0.9%), 17 (2.6%), and 1 (0.2%) transcripts had their signal intensities differing by \>2 fold between each two of these three duplicates. Twenty-six transcripts were detected from only one or two of the three samples. The signal intensities for these transcripts were low. Only one transcript in one sample had its signal intensity \>1,000, indicating that the inconsistence among the duplicates was due to low signals of these transcripts.

###### 

Detection of the 1,135 gene transcripts in various samples

  ------------------------------------------------- ----------------- -------------- ----------------- -------------- -------- --------- ----- ------- --------
  **Cell Line**                                     **ADR\***         **MCF-7**                                                                        
                                                                                                                                                       
                                                    **Single-Cell**   **100-Cell**   **10,000-Cell**   **100-Cell**                                    
                                                                                                                                                       
  **Sample**                                        **I**             **II**         **III**           **I**          **II**   **III**         **I**   **II**
                                                                                                                                                       
  **Detectable**                                    590               576            614               660            663      662       655   615     614
                                                                                                                                                       
  **Undetectable**                                  545               559            521               475            472      473       480   520     521
                                                                                                                                                       
  **Detectable in all**                             504               650                              597                                             
                                                                                                                                                       
  **Detectable in some**                            182               26                               35                                              
                                                                                                                                                       
  **Undetectable in all**                           449               459                              503                                             
                                                                                                                                                       
  **Detectable in all**                                                                                630                                             
                                                                                                                                                       
  **Detectable in some**                                                                               63                                              
                                                                                                                                                       
  **Undetectable in all**                                                                              442                                             
                                                                                                                                                       
  **Detectable in all**                                                                                               531                              
                                                                                                                                                       
  **Detectable in some**                                                                               212                                             
                                                                                                                                                       
  **Undetectable in all**                                                                              392                                             
                                                                                                                                                       
  **All ADR\*, not MCF-7**                                                                             75                                              
                                                                                                                                                       
  **Both MCF-7, not ADR\***                                                                            43                                              
                                                                                                                                                       
  **Detectable in all**                             463                                                                                                
                                                                                                                                                       
  **Detectable in some**                            315                                                                                                
                                                                                                                                                       
  **Undetectable in all**                           357                                                                                                
                                                                                                                                                       
  **Detectable in all non-single, not in single**   61                                                                                                 
                                                                                                                                                       
  **Detectable in all single, not in non-single**   27                                                                                                 
  ------------------------------------------------- ----------------- -------------- ----------------- -------------- -------- --------- ----- ------- --------

\*ADR: NCI/ADR-RES

![**Comparison of microarray results between duplicated samples**. **A**. A scatter plot of the microarray intensities of a sample with 100 NCI/ADR-RES cells were plotted against those of a duplicated 100-cell sample, and **B**, a scatter plot in **A**after replacing the data of the latter 100-cell sample with data of a 10,000-cell sample from the same cell line. Microarray intensities shown in the figure are the results after baseline subtraction. Both plots are on the log scale.](1471-2164-9-9-2){#F2}

For the two 100-cell samples from MCF-7, 615 (54.2%) and 614 (54.1%) gene transcripts were detected, respectively, with 597 (\>97%) detected in both. Of these 597 transcripts, 562 (94.1%) had signal intensities differing less than two fold. Similar to the situation with NCI/ADR-RES samples, all 34 transcripts that were detected in only one sample but not the other had low signal intensities with only nine genes whose signal intensities were \>1,000 in one of the two samples.

Because samples prepared from a large number of cells are usually associated with high reliability, we further compared the microarray results of the NCI/ADR-RES 100-cell samples with those from a 10,000-cell sample of the same cell line. Resulting data also show a high degree of correlation (r = 0.961, Figure [2B](#F2){ref-type="fig"}). As shown in Table [1](#T1){ref-type="table"}, 630 (96.7%) of the 650 gene transcripts detected from all the 100-cell samples were also detected from the 10,000-cell sample. Sixty-three gene transcripts were detected in at least one of the three 100-cell samples but not in the 10,000-cell sample, or *vice versa*. Of these 63 gene transcripts, 61 had signal intensities below 1,000 in all the three 100-cells. However, the change from 100 to 10,000 cells did enhance the detection of 21 gene transcripts whose signal intensities were \>2 fold greater in the 10,000-cell sample than those in the 100-cell samples. Among these 21 transcripts, six had signal intensities in the 10,000-cell sample more than 15 fold greater than the average intensities of the corresponding genes in the three 100-cell samples, indicating that using 10,000 cells may have significantly increased the copy numbers of these transcripts or changed their absence status to presence. These data indicate that our system not only can produce very reliable results even with as few as 100 cells but also is very sensitive to the copy number change for the low-copy-number gene transcripts.

Sensitivity of the high-throughput gene expression profiling system
-------------------------------------------------------------------

To further test the sensitivity of our high-throughput gene expression profiling system, single NCI/ADR-RES cell samples were prepared and used for multiplex gene expression assay of the 1,135 mRNA species. Microarray results from three of these samples are listed in Additional file [3](#S3){ref-type="supplementary-material"}. The numbers of gene transcripts detected from the three single-cell samples were 590, 576, and 614, respectively. Of these transcripts, 503 were detected from all single cells. Of the 503, 463 (92.0%) were also detected from all non-single-cell (100-cell and 10,000-cell) samples, indicating a prevalent expression of these genes in most, if not all, cells at relatively high levels.

On the other hand, the detection range of gene transcripts from the three single-cell samples was wider compared to the non-single-cell samples. As shown in Table [1](#T1){ref-type="table"}, 449 transcripts were undetectable in all three single cell samples, a number which is not greater than that (459) for the three 100-cell samples and is comparable to that (442) for all non-single-cell samples. The number of undetectable gene transcripts from all single and non-single cell samples is 357. This number means that from single cells, we not only detected a comparable number of genes, but also detected a new set of 449-357 = 92 genes that could not be detected with non-single-cell samples of the same cell line.

The robustness of gene expression profiling with single-cell samples was also demonstrated by the signal intensities. As described above, most transcripts that were detected from some but not all non-single-cell samples had low signal intensities and very few were \>1,000. The scenario with single cells is very different. Of the 503 gene transcripts detected from all single cells, 40 were detected in one to three non-single-cell samples but not all four. All 40 but one have signal intensity \>1,000 in at least one of the three single-cell samples. Of the 183 transcripts that were only detected from one or two single-cell samples, 108 (59.0%) had signal intensity \>1,000. The strong and robust signal intensities detected from single-cell samples indicate that our system is very sensitive.

Unlike the gene transcripts detected from all non-single-cell samples which account for more than 95% of gene transcripts detected from each of these samples, the 503 gene transcripts detected from single cells only account for 85. 3%, 87.3% and 81.9% of the transcripts detected from individual single-cell samples, respectively. Pairwise comparison of the results from the single-cell samples yielded correlation coefficients of 0.780, 0.700, and 0.711, respectively, compared with = 0.949 for the non-single-cell samples. From all single and non-single-cell samples, 778 gene transcripts were detected, of which 315 (40.5%) were detected from some but not all samples. This is in contrast with the scenario of non-single-cell samples from which gene transcripts that were only detected from some but not all samples were a very small portion (Table [1](#T1){ref-type="table"}). Furthermore, of these 315 transcripts, 177 (56.2%) were either detected from only single cells or from non-single cell samples.

The high degree of concordance among the results from the non-single-cell samples, and the significant differences among those from single cells, and between single cells and non-single-cell samples indicate that most, if not all, of these differences are real. As mentioned above, this is further supported by the robustness of the signal intensities detected from single-cell samples for the gene transcripts that were detected differently between the single cells and non-single-cell samples. It is conceivable that heterogeneity in clonality and/or genetic alterations in the cells of a cell line could be major factors contributing to the differences. In addition, a considerable portion of the cells may be at different cycle stages during which groups of genes are expressed differently. Therefore, while gene expression in single cells could differ in various aspects, 100 cells may well represent the entire cell population because, after all, the cell line cells are from the same tissue and the same donor. Therefore, genes that are detectable in a cell population may not be expressed or expressed at very low levels in certain single cells. Conversely, genes that are detectable in particular single cell samples may not be expressed or expressed at very low levels in the majority of the cell population.

Differential gene expression in the two cell lines, NCI/ADR-RES and MCF-7
-------------------------------------------------------------------------

When the gene expression profiles of NCI/ADR-RES were compared with those of MCF-7, a considerable number of genes were shown to be expressed differentially in these two cell lines. Of the 1,135 gene products, 531 (46.8%) were detected from samples of both cell lines (not including single cell samples). Seventy-five gene transcripts were detected in all NCI/ADR-RES non-single-cell samples, but not in the MCF-7 samples, and 43 were detected in the opposite way.

Of the 118 differentially expressed genes, 69 were shown to be expressed with more than 10-fold difference (Table [2](#T2){ref-type="table"}). Of the 69 genes, 37 (53.6%) were detected as strongly or relatively strongly expressed in MCF-7, but weakly or not expressed in NCI/ADR-RES, and 32 were detected in the opposite way. To validate the gene expression data, 22 of these 69 genes, and another 46 gene transcripts detected with various microarray signal intensities different between the samples of the two cell lines were randomly selected (Table [3](#T3){ref-type="table"}) and subjected to RT-PCR amplification individually. The amplified products were resolved by gel electrophoresis. The signal intensities of the respective bands were quantified with a gel documentation system. Part of results from microarrays and gel assays are shown in Fig. [3](#F3){ref-type="fig"}.

###### 

Differentially expressed genes in the two cell lines, MCF-7 and NCI/ADR-RES

  **Category**                          **Gene Ref\#**   **Probe ID**   **Gene Symbol**   **Log~2~Ratio (NCI/ADR-RES:MCF-7)**
  ------------------------------------- ---------------- -------------- ----------------- -------------------------------------
  Overexpressed genes in NCI/ADR-RES    NM_004126        BYH0575        GNG11             6.69
                                        NM_004355        BYH0596        CD74              6.38
                                        NM_005822        BYH0767        DSCR1L1           6.20
                                        NM_005238        BYH0702        ETS1              6.06
                                        NM_002019        BYH0339        FLT1              5.99
                                        NM_000110        BYH0058        DPYD              5.81
                                        NM_001792        BYH0302        CDH2              5.65
                                        NM_001336        BYH0239        CTSZ              5.63
                                        NM_024423        BYH1071        DSC3              5.60
                                        NM_001250        BYH0223        CD40              5.51
                                        NM_001511        BYH0257        CXCL1             5.36
                                        NM_000873        BYH0185        ICAM2             5.32
                                        NM_032727        BYH1080        INA               5.09
                                        NM_005465        BYH0738        AKT3              4.98
                                        NM_003118        BYH0466        SPARC             4.94
                                        NM_001561        BYH0267        TNFRSF9           4.91
                                        NM_000576        BYH0143        IL1B              4.62
                                        NM_003644        BYH0527        GAS7              4.62
                                        NM_001953        BYH0328        ECGF1             4.62
                                        NM_001839        BYH0312        CNN3              4.57
                                        NM_033293        BYH1093        CASP1             4.47
                                        NM_015873        BYH0979        VILL              4.47
                                        NM_057162        BYH1100        KLHL4             4.39
                                        NM_021913        BYH1052        AXL               4.33
                                        NM_000700        BYH0168        ANXA1             4.23
                                        NM_000584        BYH0145        IL8               4.18
                                        NM_000088        BYH0052        COL1A1            4.10
                                        U28727           BYH1107        PAPPA             4.00
                                        NM_001150        BYH0210        ANPEP             3.62
                                        NM_003659        BYH0530        AGPS              3.61
                                        NM_006097        BYH0797        MYL9              3.43
                                        NM_012449        BYH0928        STEAP1            3.35
                                                                                          
  Underexpressed Genes in NCI/ADR-RES   NM_001789        BYH0300        CDC25A            -3.34
                                        NM_014427        BYH0960        CPNE7             -3.38
                                        NM_004708        BYH0646        PDCD5             -3.53
                                        NM_005235        BYH0700        ERBB4             -3.63
                                        NM_001702        BYH0281        BAI1              -3.68
                                        NM_005568        BYH0743        LHX1              -3.70
                                        NM_005994        BYH0787        TBX2              -3.78
                                        NM_033016        BYH1086        PDGFB             -3.83
                                        NM_001759        BYH0291        CCND2             -3.89
                                        NM_006180        BYH0803        NTRK2             -3.90
                                        NM_000090        BYH0054        COL3A1            -4.00
                                        NM_002051        BYH0343        GATA3             -4.18
                                        NM_001422        BYH0247        ELF5              -4.24
                                        NM_000429        BYH0117        MAT1A             -4.32
                                        NM_000633        BYH0158        BCL2              -4.57
                                        NM_000949        BYH0193        PRLR              -4.59
                                        NM_014333        BYH0955        CADM1             -4.79
                                        NM_002555        BYH0402        SLC22A18          -5.00
                                        NM_003722        BYH0533        TP73L             -5.01
                                        NM_021111        BYH1039        RB1               -5.09
                                        NM_012116        BYH0906        CBLC              -5.15
                                        NM_000550        BYH0139        TYRP1             -5.17
                                        AF055033         BYH0006        IGFBP5            -5.52
                                        X52599           BYH1117        NGFB              -5.53
                                        NM_000027        BYH0029        AGA               -5.54
                                        M35410           BYH0025        IGFBP2            -5.59
                                        NM_003486        BYH0521        SLC7A5            -5.75
                                        NM_018684        BYH1015        KIAA1166          -6.08
                                        NM_000362        BYH0102        TIMP3             -6.14
                                        NM_004378        BYH0600        CRABP1            -6.79
                                        NM_005410        BYH0726        SEPP1             -6.79
                                        NM_001719        BYH0284        BMP7              -6.83
                                        NM_003282        BYH0499        TNNI2             -7.06
                                        NM_004048        BYH0570        B2M               -7.07
                                        NM_003177        BYH0473        SYK               -7.18
                                        NM_004561        BYH0622        OVOL1             -7.20
                                        NM_000609        BYH0154        CXCL12            -8.3

###### 

Comparison between the results from microarray and gel assay\*

                       **Microarray Intensity**   **Gel Assay Intensity**   **Ratio ADR/MCF-7**                     
  --------- ---------- -------------------------- ------------------------- --------------------- -------- -------- -------
  **I**     BAI1       1,192                      12,372                    4,578                 1,320    0.10     3.47
            SSTR2      9,206                      19,108                    2,887                 7,684    0.48     0.38
            MCL1       17,027                     31,012                    7,481                 8,901    0.55     0.84
            TPM2       8,582                      14,489                    34,703                13,186   0.59     2.63
            ACOX1      8,125                      13,350                    26,206                19,508   0.61     1.34
            MGAT4B     2,274                      3,219                     1,053                 922      0.71     1.14
            UBQLN1     27,113                     38,083                    24,037                20,089   0.71     1.20
            RAB3B      28,188                     31,908                    33,571                31,044   0.88     1.08
            DNMT1      25,315                     27,675                    41,164                43,718   0.91     0.94
            BUB1B      13,233                     14,452                    21,197                14,321   0.92     1.48
            PRDM10     13,233                     14,452                    9,419                 6,641    0.92     1.42
            NOTCH3     7,187                      7,618                     26,090                24,176   0.94     1.08
            YY1        27,020                     27,930                    40,692                33,876   0.97     1.20
            TPR        13,081                     13,176                    32,959                26,423   0.99     1.25
            PTTG1IP    12,506                     12,298                    15,621                12,424   1.02     1.26
            PPP2R4     16,105                     15,740                    15,593                19,497   1.02     0.80
            YES1       21,006                     20,434                    18,228                14,830   1.03     1.23
            ZNF670     23,207                     22,487                    6,581                 6,904    1.03     0.95
            RAP1GDS1   16,806                     15,385                    32,743                22,443   1.09     1.46
            CKS2       21,507                     19,672                    10,614                9,289    1.09     1.14
            HDAC3      26,309                     22,572                    28,826                29,169   1.17     0.99
            GAPDH      9,369                      7,916                     34,584                33,939   1.18     1.02
            PTTG1      12,802                     10,790                    18,680                16,447   1.19     1.14
            HSPA5      19,233                     16,146                    17,077                15,423   1.19     1.11
            ACTB       6,849                      4,400                     35,335                35,859   1.56     0.99
            ASPH       10,942                     4,035                     20,194                3,502    2.71     5.77
            S100A2     3,498                      1,057                     13,688                9,559    3.31     1.43
            TFG        13,571                     3,915                     14,015                15,954   3.47     0.88
            EGFR       6,841                      1,676                     34,449                7,738    4.08     4.45
            RELA       8,209                      1,970                     20,099                12,783   4.17     1.57
            VIM        12,172                     2,192                     48,836                2,518    5.55     19.39
            RTN1       8,770                      1,133                     17,159                2,008    7.74     8.55
                                                                                                                    
  **II**    CRABP1     94                         8,594                     0                     21,529   0.01     0.00
            BMP7       92                         8,825                     0                     43,366   0.01     0.00
            TIMP3      92                         5,428                     0                     17,135   0.02     0.00
            AGA        90                         3,457                     0                     20,178   0.03     0.00
            CXCL12     97                         24,456                    28                    16,471   0.00     0.00
            B2M        98                         10,621                    990                   13,599   0.01     0.07
            TYRP1      181                        5,380                     2,125                 7,089    0.03     0.30
            PDGFB      352                        4,080                     2,460                 6,627    0.09     0.37
            GATA3      176                        2,618                     2,780                 4,343    0.07     0.64
            SEPP1      84                         7,626                     3,056                 4,432    0.01     0.69
            TBX2       202                        2,255                     4,808                 9,482    0.09     0.51
            HDAC5      243                        1,266                     16,605                7,834    0.19     2.12
                                                                                                                    
  **III**   ETS1       22,413                     280                       40,334                0.00     79.97    \-
            SPARC      9,959                      266                       44,142                0.00     37.45    \-
            DSC3       18,136                     304                       8,076                 0.00     59.62    \-
            CD40       17,887                     319                       15,499                0.00     56.04    \-
            FLT1       16,379                     209                       4,032                 371      78.23    10.87
            INA        18,499                     438                       7,908                 411      42.27    19.23
            CASP1      8,146                      298                       17,307                447      27.34    38.72
            CDH2       12,318                     200                       10,259                477      61.58    21.53
            GNG11      26,835                     213                       21,000                576      126.28   36.49
            MYL9       4,007                      302                       27,023                1,017    13.26    26.57
            CITED1     996                        253                       9,542                 2,606    3.93     3.66
            DAB2       1,568                      297                       32,458                5,136    5.28     6.32
            CTSZ       12,657                     211                       22,322                17,993   59.87    1.24
                                                                                                                    
  **IV**    GNRHR      92                         214                       27                    0.00     0.43     \-
            STK32B     82                         208                       0.00                  241      0.39     0.00
            IL13       82                         191                       0.00                  464      0.43     0.00
            CDH5       88                         213                       0.00                  519      0.41     0.00
            IL3        95                         203                       86                    162      0.47     0.53
            LYL1       85                         218                       128                   64       0.39     2.01
            CA1        87                         192                       365                   95       0.45     3.83
            TYROBP     91                         199                       487                   169      0.46     2.89
            IL13RA2    87                         187                       1,771                 433      0.47     4.09
            IRF8       86                         212                       3,695                 571      0.41     6.47
            MMP11      145                        234                       3,060                 2,308    0.62     1.33

Note: 1. Signal intensities of microarray are averages of those respective non-single cell samples. 2. ADR: NCI/ADR-RES.

![**Differential gene expression in the two cell lines, MCF-7 and NCI/ADR-RES**. **Upper**, Microarray images from the two cell lines. **Lower**, confirmation of the gene expression profiling results by gel assay. Quantitative results are given in Table 3. M, MCF-7, and A, NCI/ADR-RES.](1471-2164-9-9-3){#F3}

Table [3](#T3){ref-type="table"} summarizes the results from both microarray and gel assays. Based on the results from microarray, genes in Table [3](#T3){ref-type="table"} are subdivided into four groups. Transcripts of Group I genes were detected from all samples, while no transcripts were detectable from all samples for Group IV. Transcripts of Group III genes were detected only from the NCI/ADR-RES samples but not from the MCF-7 samples, and those of Group II genes were detected in an opposite way. As shown, the signal ratios between NCI/ADR-RES and MCF-7 from microarray for the Group I genes are well in concordance with the ratios from gel assay, with a correlation coefficient of 0.679, indicating results from microarray and gel assays match very well. Because signals of genes in Groups II to IV were below the background for at least one of the two cell lines, ratio comparison may not be meaningful. However, it is clear that the microarray signals detected from MCF-7 are all greater than those from NCI/ADR-RES for the Group II genes, and *vice versa*for the Group III genes. Results from the gel assay are very well in concordance with this correlation. The only exception is HDAC5 whose microarray signal from MCF-7 is approximately 5 times that from NCI/ADR-RES, while its gel signal is more than 2 times that of the latter. Since the microarray signal intensity from MCF-7 for this gene is the lowest among the Group II genes, this discrepancy could be caused by wider variation of the low signal intensity. For all genes in Groups II to IV, if the microarray signals are lower than background, the corresponding gel signals are also low (\<5,000) except for three genes, HDAC5 in Group II, and DAB2 and CTSZ in Group III. The fact that low or relatively low signals were detected by the gel assay for the genes whose array signals were weaker than background may be a reflection of the difference between the two assays. For microarray, all 1,135 transcripts were amplified in the same tube, while all transcripts analyzed by gel assay were amplified individually. It is known that during PCR, after the reaction reaches a saturation point, very little additional products may be generated. When the gene transcripts are amplified in a multiplex way, certain low-copy-number sequences may not be amplified to the detectable amounts when the reaction reaches a saturation point.

Specificity of the high-throughput gene expression system
---------------------------------------------------------

The specificity of our high-throughput gene expression system was demonstrated by the results from different cell line samples and by those from different single cells as described above. To further demonstrate the specificity of our system, human genomic DNA samples were amplified with the same multiplex RT-PCR procedure and analyzed by microarray. Very few probes (\<0.2%) were shown to have signals above background (data not shown), indicating that our system is very specific and can discriminate between the target mRNA sequences from their genomic counterparts, and therefore, the unprocessed transcripts. Our previous experience also showed that in the absence of specific templates, a few primer sets may amplify non-specific sequences. However, such non-specific amplification may become undetectable in the presence of specific templates because the specific sequences are much stronger in competition. In addition, using specially designed probes also enhanced the specificity.

Discussion
==========

Compared with other existing gene expression profiling methods, our approach has the following advantages:

(1) Highly specific
-------------------

To date, no other high-throughput system has been reported to be highly discriminative of mRNA from other related DNA and RNA sequences. Using primers amplifying sequences across intron(s) and probes consisting of sequences in adjacent exons is a critical enhancement to achieve such high specificity. Furthermore, all primer, probe and amplicon sequences were subjected to exhaustive searches against the databases of the entire human genome and transcriptome to ensure these sequences are unique. Such a step was proven very effective for enhancing the specificity \[[@B12]\]. Experimentally, when genomic DNA was used as samples, signals were only detected for only 2 or 3 genes (0.2%) out of the 1,135 genes. Based on our previous studies, these signals may become undetectable in the presence of specific sequences which may compete out the nonspecific amplification.

(2) Highly sensitive
--------------------

We showed previously that our multiplex amplification system could detect \>1,000 single-copy sequences simultaneously from single haploid sperm cells \[[@B12]\]. The fact that \>90% of these sequences are detectable indicates that with our specially designed primers, most, if not all, sequences may be well amplified parallelly with very limited, if any, interaction among the primers. Since the primers used for gene profiling are designed in the same way, it is reasonable to believe that most gene transcripts are also amplified parallelly. However, since the copy number of different gene transcripts in the cells varies in a wide range, the outcome of amplification would be different from that using single-copy sequences. When only single-copy sequences are used in multiplex amplification, most, if not all, sequences may reach the detectable amount before the system is saturated. However, when gene transcripts are amplified, whether a transcript reaches a detectable amount before the system is saturated depends on its copy number in the sample, and not all sequences may reach a detectable amount at the end of amplification. This is probably why some sequences were undetectable by microarray but detectable by gel assay.

With our system, a total of 686 gene transcripts were detected from three single cells, which is comparable to 676 for the three 100-cell samples and 693 for all non-single-cell samples from the same cell line. The sensitivity of our system is further proved by the facts that results from 100-cell samples are very similar to each other and to those from 10,000 cells, and that specific gene expression profiles were obtained from different cell lines using as few as 100 cells.

The sensitivity of our system is further illustrated by the results that a significant portion of transcripts that could not be detected from the NCI/ADR-RES samples but were detected from the MCF-7 samples or single cell samples, and *vice versa*. This also indicates that low microarray intensities for these transcripts were not false negatives, and they were either not present or present in very low abundance in the respective samples.

(3) Very simple
---------------

Unlike other methods that involve multiple steps and use multiple enzymes, our method allows a large number of gene products amplified by a single RT-PCR step directly from cell lysates without RNA extraction. In this way, a large number of samples may be analyzed easily and cost-effectively. Our simple experimental procedure is also the basis of the high degree of sensitivity since it avoids complicated mRNA extraction and processing procedures before and during amplification, which may cause mRNA degradation or loss.

(4) Very safe for RNA samples
-----------------------------

When working with RNA, one has to take extra precaution to prevent mRNA from degradation. Our method does not need RNA extraction. Once cells are lysed, RNA is directly released to the RT-PCR buffer and used as template immediately. There is almost no chance for RNase to degrade the mRNA templates.

(5) Highly flexible
-------------------

Many studies may not need to analyze all genes in the human genome and may often need to focus on different gene groups. Therefore, flexibility of the experimental system would be highly desirable. With our computer program, a large number of gene products can be designed into a single multiplex group. Genes can be easily organized into different subgroups upon need, and can also be re-grouped at any time without altering the reaction conditions. New gene products can be added to an existing set easily.

The capacity of multiplex RT-PCR is another concern for high-throughput gene expression profiling because it not only makes the amplification of a large number of gene products affordable and cost-effective, but also eliminates challenges involved in quality control of RT-PCR for a large number of genes individually \[[@B33],[@B34]\]. However, the capacity of multiplex amplification was limited by interaction between primers. A previous study reported a screening of 29 expressed genes using multiplex RT-PCR, but was unable to reduce the number of the reaction tubes less than eight \[[@B35]\]. Other studies multiplexed up to nine genes with nonspecific RT primers \[[@B36],[@B37]\]. Studies using multiple sets of gene-specific primers in single reactions were also reported, but none of these generated enough products for the analysis of all expressed genes in the samples \[[@B34],[@B38]\]. In the present study, we report our success with multiplex RT-PCR for 1,135 mRNA species. Such a success was based on a combination of several technological developments, including computerized primer design with predicted minimal interaction, a narrow primer T~m~range, small amplicon sizes, and optimization of amplification conditions based on our previous experience \[[@B12],[@B29],[@B30]\]. With our current protocol, it is possible to include two thousand or more gene transcripts in a single multiplex amplification group, and to analyze all human gene transcripts using several multiplexing amplification groups. After pooling amplified products from the multiplexing groups, all genes may be analyzed with a single microarray. With our system, large-scale gene expression profiling becomes highly affordable and cost-effective. If the primers and probes used in the high-throughput analysis are made accessible to the research community through a distribution system, large- and genome-scale gene expression profiling may be even more affordable and cost-effective.

A major limitation of our system is the requirement of presence of large introns in genes under study. When the introns are small, discrimination between mRNA and closely related DNA and RNA sequences is still possible by using probes consisting of sequences in the neighboring exons. For genes with no introns, primers and probes can be designed only to discriminate mRNA sequences from related pseudogenes and their transcripts but not the corresponding gene sequences. In this case, discrimination between mRNAs and their gene sequences is only possible when the mRNAs are present abundantly.

An extreme and possible application of our highly sensitive gene expression profiling system is the analysis of disseminated tumor cells in cancer research. Analysis of individual cells is necessary for understanding the early dissemination of tumor cells. Disseminated tumor cells remain in the patient bodies even after complete resection of the primary tumor, and can be obtained by bone marrow aspirates \[[@B39]\]. With our highly sensitive system, genetic signature in these cells may be detected. The resulting information may provide molecular basis for new therapeutic targets. For example, *ERBB2*expression has been found to be a therapeutic target for metastatic breast carcinoma \[[@B40]\]. Identification of mRNA like that of *ERBB2*in micrometastatic cells may help develop effective therapeutical approaches to preventing further development of these cells into incurable metastasis. Using mRNA from a small number of microdissected frozen tissue sections without RNA isolation has been demonstrated with a small number of genes \[[@B41]\]. Our system should be capable of using both microdissected and biopsy specimens for gene expression analysis on a much larger scale.

High-throughput gene expression profiling with single cells is also interesting for most laboratories studying molecular neurophysiology, but has been hampered by the capacity of multiplex PCR. Our approach can be used to examine the expression of many genes within individual neurons or other cells. The gene expression profiles can also be correlated to the phenotypes of these cells such as morphological, electrophysiological and pharmacological features to understand the underlying molecular mechanisms.

Conclusion
==========

This report describes a high-throughput gene expression profiling technology, which is simple, highly reproducible, specific and sensitive, and may greatly facilitate gene expression profiling of a small number of or even single cells. It may also be applicable to many applications where the amount of material is limited, and to diagnostic assays that identify the onset of cancer and monitor its progression, remediation or response to treatments.

Data discussed in this publication have been deposited in the NCBI\'s Gene Expression Omnibus \[[@B31]\] and are accessible through GEO Series accession number GSE5920.

Methods
=======

Cell lines and single cell preparation
--------------------------------------

Human breast cancer cell line MCF-7 and ovarian cancer cell line NCI/ADR-RES were kindly provided by Drs. Jinming Yang, Hao Wu and William Hait \[[@B42]\]. The cell lines were maintained in RPMI 1640 medium containing 10% fetal bovine serum, 100 units/ml penicillin, and 100 μg/ml streptomycin at 37°C in a humidified atmosphere containing 5% CO~2~. After counting with a hemacytometer, cells were suspended in PBS (phosphate buffer solution) to 1000 cells/μl or other desirable densities. Two μl was dispensed into an Eppendorf tube containing cell lysis buffer (1.5 μl RNase inhibitor, 4 μl of 5× QIAGEN OneStep RT-PCR buffer, 12.5 μl H~2~O). Single cells were prepared from a diluted cell suspension of 2 cells/μl in 1 × PBS. About 0.5 μl of the suspension was pipetted onto a small piece of glass coverslip, and was checked under a microscope. If the droplet contained only one cell, the piece of the coverslip was then transferred into an Eppendorf tube containing the cell lysis buffer. The tube was immediately frozen in an ethanol/dry ice bath and stored at -80°C until use.

Selection of genes for mRNA profiling
-------------------------------------

Genes used in the present study were selected based on previous publications \[[@B15]-[@B28]\], and are those involved in fundamental cell functions such as cell cycle, apoptosis, cell matrix, DNA repair, DNA replication, somatic recombination, RNA transcription and regulation, and protein translation and regulation. The borders between exons and introns for the selected genes were determined by aligning of the mRNA to genomic sequences using the BLAT program \[[@B43]\] maintained by the University of California, Santa Cruz.

Primer and probe design
-----------------------

A computer program was written for primer and probe selection. Each pair of PCR primers was designed to amplify sequences in two adjacent exons flanking a large intron and to ensure specific amplification of the desirable mRNA sequences rather than the respective gene or unprocessed RNA sequences. To enhance the amplification specificity, the program always searches for candidate amplicon sequences separated by large introns in each gene. The melting temperatures (T~m~\'s) for all selected primers ranged from 50.1°C to 61.6°C, and the GC-contents ranged from 32% to 70%. The lengths of the amplicons ranged from 72 to 150 bases.

Each oligonucleotide probe for microarray analysis was designed to consist of sequences of two adjacent exons to specifically interrogate the cDNA from corresponding mRNA sequence, but not the corresponding gene sequences or cDNA from unprocessed RNA. To facilitate microarray analysis, the 3\'-ends of all probes terminated before a \"G\" base in the template sequence so that they can be labeled with the same fluorescent color by incorporating fluorescently labeled Cy5-ddCTP. The lengths of the probes ranged from 22 to 31 bases, and the GC-content of the probes ranged from 30% to 70% with their T~m~\'s from 54.4°C to 65.2°C.

The BLAST executable program and sequence databases were downloaded from NCBI website \[[@B44]\] and installed to a local server. All the primers were subjected to BLAST search both in the human genome and the transcriptome databases to avoid amplification of nonspecific genomic or RNA sequences including pseudogenes and their RNA products. In addition, all primers and probes were subjected to interaction analysis with a computer program developed for designing high-throughput multiplex nucleotide acid detection \[[@B12]\]. Probes complementary to intron regions of some genes were also designed as negative controls. All amplicon sequences were subjected to BLAST search to ensure their uniqueness. Details about the primer and probe design for the high-throughput multiplex nucleic acid detection may be found in our previous publication \[[@B12]\].

Gene-specific reverse transcription and multiplex RT-PCR
--------------------------------------------------------

Cells in the lysis buffer described above were lysed with three repeating cycles of alternating one-min incubations from the ethanol/dry ice mix to a 37°C water bath before RT-PCR. One-step RT-PCR was carried out in a 50-μl reaction containing primers (20 nM each) for all the 1,135 mRNA species, 2.5 mM MgCl~2~, the four dNTPs (400 μM each), and 2.0 μl QIAGEN OneStep RT-PCR Enzyme Mix without degenerated primers. The samples were first incubated at 50°C for 40 min for cDNA synthesis, and then were heated to 95°C for 15 min to inactivate the reverse transcriptase and activate the *Taq*DNA polymerase followed by 45 PCR cycles. Each PCR cycle consisted of 40 sec at 94°C for denaturation, and 1 min at 55°C and 5 min of ramping from 55°C to 70°C for annealing and extension. A final extension step was carried out at 72°C for 3 min at the end of the PCR. All PCRs were performed with the PTC100 Programmable Thermal Controllers (MJ Research). Single-stranded DNA (ssDNA) was generated by using the same conditions in multiplex PCR except for the templates that were 10 μl of the multiplex RT-PCR product. Only one primer for each sequence was used, and 40 thermal cycles were carried out.

RT-PCR with individual gene transcripts
---------------------------------------

RT-PCRs with individual gene transcripts were performed for a group of genes with different amounts of signal intensities detected from the two cell lines, NCI/ADR-RES and MCF-7. For each gene, an aliquot (equivalent of 100 cells) from the same cell lysate used for multiplex gene expression profiling was used. Conditions for one-step RT-PCR were similar to those for multiplex one-step RT-PCR. mRNAs transcribed from β-actin and α-tubulin genes served as internal controls. The PCR products were assayed by gel electrophoresis. Gels were imaged using an Image Station (Model 440, Kodak, New Haven, CT, USA). Gel band intensities were digitized with the software, Kodak 1D 3.5.

### Microarray design, hybridization, and probe labeling by single-base extension assay

Oligonucleotide probes were printed onto glass slides in duplicate with a spot diameter of 160 μm and a center-to-center distance of 250 μm by using the OmniGrid Accent Microarrayer (Gene Machines, CA). One hundred fourteen spots with only microarray printing buffer without probes were used as negative controls and were distributed spatially evenly across each array. Microarray analysis was performed according to a four-step procedure established in our laboratory \[[@B12]\]. Briefly, (1) preparation of microarray slides: Pre-cleaned Gold Seal Micro slides (Becton Dickinson) with no scratch were chosen, and were soaked in 30% bleach with shaking for 1--2 hrs followed by rinsing five times with deionized H~2~O and three times with MilliQ H~2~O. Slides were then sonicated in 15% Fisher brand Versa-Clean Liquid Concentrate with heat on for 1--2 hrs followed by rinsing with shaking 10 times in deionized H~2~O and five times in MilliQ H~2~O. Slides were dried by centrifugation at 1,000 rpm for 5 min with a slide holder in a GS-6 Beckman centrifuge, and then were baked at 140°C in a vacuum oven for 4--5 hrs (Fisher Scientific Model 280A); (2) microarray preparation: each oligonucleotide probe was mixed with the Microarray Printing Solution (GenScript, Piscataway NJ) at a 1:5 ratio (v/v) to a final concentration of 50 μM in a well of a 384-well plate. Probes were then arrayed onto the washed glass slides with humidity between 50% and 55%, and temperature between 24.5°C to 26.5°C; (3) hybridization: Each glass slide with probe arrays was placed into a Corning slide cassette. Hybridization was performed in 30 μl of 1× hybridization solution (5× Denhart\'s solution, 0.5% SDS, 3 × SSC, 20 μl of ssDNA at 56°C for 2 hrs. The cassette was briefly soaked in iced water before opening. The slide was then washed with 1 × SSC and 0.1% SDS at 56°C for 10 min, rinsed twice with 0.5 × SSC for 30 sec and twice with 0.2 × SSC for 30 sec; and (4) probe labeling by single base extension: microarrays consisting of oligonucleotide probes were covered with 25 μl 1× labeling solution containing 20 units of Sequenase, 1× Sequenase buffer (GE Healthcare Life Sciences, Piscataway, NJ), and 750 nM Cy5-ddCTP (Applied Biosystems, Foster City, CA). The labeling reaction was performed at 70°C for 10 min. The slide was washed again under the same conditions used after hybridization.

Microarray scanning and data analysis
-------------------------------------

Microarrays were scanned with a GenePix 4000 scanner (Axon Instruments, Foster City, CA). The resultant images were digitized with the accompanying software Genepix Pro (version 4.0). The mean values of the signals from the duplicate spots of each probe were used for the analysis in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. Background signal was determined by using negative control probes that were complementary to the intron sequences of the corresponding genes or random sequences, and was subtracted from the sample signals. For the comparative expression analysis of the cell lines MCF-7 and NCI/ADR-RES in Table [1](#T1){ref-type="table"}, the array data were normalized by the Lowess smoothing method \[[@B45],[@B46]\]. After background subtraction, genes with negative values of signal intensities in both duplicated samples were excluded for further analysis. The log ratios of the intensities of the remaining genes in two cells lines were used to make calls and to identify the differentially expressed genes in the samples.
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